Value-Based Reimbursement Decisions for Orphan Drugs: A Scoping Review and Decision Framework
Our framework may be used to structure policy discussions and to aid transparency about the values underlying reimbursement decisions for orphan drugs. These values ought to be consistently applied to all technologies and populations affected by the decision. </AbstractSection> Copyright The Author(s) 2015
Year of publication: |
2015
|
---|---|
Authors: | Paulden, Mike ; Stafinski, Tania ; Menon, Devidas ; McCabe, Christopher |
Published in: |
PharmacoEconomics. - Springer, ISSN 1170-7690. - Vol. 33.2015, 3, p. 255-269
|
Publisher: |
Springer |
Saved in:
Online Resource
Saved in favorites
Similar items by person
-
Stafinski, Tania, (2011)
-
Health Technology Funding Decision-Making Processes Around the World: The Same, Yet Different
Stafinski, Tania, (2011)
-
Transparency in Reimbursement Decisions: In Whose Best Interest?
Stafinski, Tania, (2014)
- More ...